| 发明名称 |
PHARMACEUTICAL FORMULATION AND METHOD OF TREATMENT USING THE SAME |
| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide pharmaceutical formulations containing at least one compound of Formulae I-XXVI in the specification, and at least one surfactant. <P>SOLUTION: Pharmaceutically acceptable carriers and excipients can also be included in the formulations. The formulations are suited for use in single unit dosages. Such formulations can be useful for inhibiting HCV protease and/or capthesin activity and have good dissolution characteristics to facilitate absorption of the compounds of Formulae I-XXVI. <P>COPYRIGHT: (C)2013,JPO&INPIT |
| 申请公布号 |
JP2012250996(A) |
申请公布日期 |
2012.12.20 |
| 申请号 |
JP20120205626 |
申请日期 |
2012.09.19 |
| 申请人 |
MERCK SHARP & DOHME CORP |
发明人 |
MALCOLM BRUCE A;BRADLEY PRUDENCE K;PAVLOVSKY ANASTASIA;CHO WING-KEE PHILIP;QIU ZHIHUI |
| 分类号 |
A61K45/08;A61K38/00;A61K47/20;A61P1/02;A61P1/04;A61P1/16;A61P3/10;A61P9/00;A61P11/02;A61P11/06;A61P17/00;A61P17/06;A61P17/14;A61P19/02;A61P19/10;A61P25/00;A61P25/16;A61P25/28;A61P27/02;A61P29/00;A61P31/10;A61P31/14;A61P35/00;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07K5/08;C07K5/10;C07K7/00 |
主分类号 |
A61K45/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
